Published in Metabolism on May 01, 2008
Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res (2005) 11.88
The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer (2008) 5.07
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol (2006) 3.74
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene (2002) 2.36
LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study. J Clin Endocrinol Metab (2013) 2.30
Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens (2006) 2.09
Anaplastic lymphoma kinase in human cancer. J Mol Endocrinol (2011) 1.95
New and old functions of STAT3: a pivotal target for individualized treatment of cancer. Cell Cycle (2005) 1.89
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood (2002) 1.87
Drug-eluting stents in vascular intervention. Lancet (2003) 1.83
Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol (2003) 1.79
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. Nat Med (2012) 1.67
Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom (2004) 1.51
Left ventricular structural and functional characteristics in Cushing's syndrome. J Am Coll Cardiol (2003) 1.38
Essential role of PDK1 in regulating endothelial cell migration. J Cell Biol (2007) 1.35
Expanding role of AMPK in endocrinology. Trends Endocrinol Metab (2006) 1.29
Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens (2002) 1.24
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study. J Clin Oncol (2013) 1.22
High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol (Oxf) (2004) 1.21
Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab (2005) 1.19
S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase. Am J Pathol (2002) 1.17
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase. Blood (2005) 1.16
Adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab (2012) 1.12
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome. FASEB J (2008) 1.11
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens (2007) 1.10
Cardiovascular risk in Cushing's syndrome. Pituitary (2004) 1.07
Pathophysiology of dyslipidemia in Cushing's syndrome. Neuroendocrinology (2010) 1.07
p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity. EMBO J (2007) 1.06
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol (2010) 1.04
Self image and quality of life in acromegaly. Pituitary (2002) 1.03
MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood (2013) 1.02
Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway. Mol Pharmacol (2006) 1.01
Descending thoracic aortic diseases: stent-graft repair. Radiology (2003) 1.01
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Blood (2012) 1.01
Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome. Eur J Endocrinol (2004) 1.00
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. J Clin Endocrinol Metab (2008) 1.00
Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and pseudo-Cushing state: a comparative study. Clin Endocrinol (Oxf) (2011) 0.99
Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril (2008) 0.99
Coagulopathy in Cushing's syndrome. Neuroendocrinology (2010) 0.99
Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? Hematol Oncol (2009) 0.98
Aortic dimensions in patients with bicuspid aortic valve without significant valve dysfunction. Am J Cardiol (2005) 0.98
Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol (2002) 0.97
Testosterone and cardiovascular risk. Intern Emerg Med (2013) 0.97
Adipose tissue as an endocrine organ? A review of recent data related to cardiovascular complications of endocrine dysfunctions. Clin Exp Hypertens (2004) 0.97
Hypoxia transcriptionally induces macrophage-inflammatory protein-3alpha/CCL-20 in primary human mononuclear phagocytes through nuclear factor (NF)-kappaB. J Leukoc Biol (2007) 0.97
Distinctive modulation of inflammatory and metabolic parameters in relation to zinc nutritional status in adult overweight/obese subjects. J Nutr Biochem (2009) 0.97
Aortic dilatation in patients with bicuspid aortic valve. J Cardiovasc Med (Hagerstown) (2006) 0.96
Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice. J Neuropathol Exp Neurol (2004) 0.96
Role of nitric oxide concentrations on human sperm motility. J Androl (2004) 0.95
Aldosterone as a cardiovascular risk factor. Trends Endocrinol Metab (2005) 0.94
Coenzyme Q(10) supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. Fertil Steril (2004) 0.94
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood (2013) 0.94
Late cardiac perforation after transcatheter closure of patent foramen ovale. Ann Thorac Surg (2006) 0.93
Pathobiology of anaplastic large cell lymphoma. Adv Hematol (2011) 0.93
The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways. Invest New Drugs (2014) 0.93
Psychosocial impairment in patients treated for pituitary disease: a controlled study. Clin Endocrinol (Oxf) (2007) 0.91
Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome. Eur J Endocrinol (2006) 0.90
Managing Cushing's disease: the state of the art. Endocrine (2014) 0.90
Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse. Int J Cancer (2004) 0.90
Harmful effects of functional hypercortisolism: a working hypothesis. Endocrine (2013) 0.90
Inverse relationship between p27/Kip.1 and the F-box protein Skp2 in human astrocytic gliomas by immunohistochemistry and Western blot. Neurosci Lett (2002) 0.89
Vascular endothelial growth factor and microvessel density in periodontitis patients with and without diabetes. J Periodontol (2009) 0.89
The role of transthoracic echocardiography in the diagnosis and management of acute type A aortic syndrome. Am Heart J (2011) 0.89
Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma. Blood (2013) 0.88
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas. BMC Endocr Disord (2010) 0.88
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma. Front Oncol (2012) 0.88
Tumor necrosis factor-alpha gene -308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron Artery Dis (2005) 0.88
In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells. J Clin Endocrinol Metab (2003) 0.87
Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations. Pituitary (2015) 0.86
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma. Haematologica (2013) 0.86
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. J Clin Endocrinol Metab (2013) 0.85
Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists. Curr Vasc Pharmacol (2012) 0.85
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis. Trends Endocrinol Metab (2008) 0.85
Sexual symptoms in endocrine diseases: psychosomatic perspectives. Psychother Psychosom (2007) 0.85
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome. Eur J Endocrinol (2011) 0.85
Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial. Pituitary (2015) 0.85
Correlates of perceived health related quality of life in obese, overweight and normal weight older adults: an observational study. BMC Public Health (2014) 0.84
Transesophageal echocardiography-guided algorithm for stent-graft implantation in aortic dissection. J Vasc Surg (2004) 0.84
Management of primary aldosteronism: its complications and their outcomes after treatment. Curr Vasc Pharmacol (2009) 0.83
Anorexia nervosa: a role for L-arginine supplementation in cardiovascular risk factors? Int J Eat Disord (2010) 0.83
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line. Genes Chromosomes Cancer (2013) 0.83
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance. Diabetes Care (2012) 0.83
Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension. Am J Hypertens (2005) 0.83
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor. Clin Endocrinol (Oxf) (2003) 0.83
Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril (2005) 0.83
Sexual dysfunctions in men affected by autoimmune Addison's disease before and after short-term gluco- and mineralocorticoid replacement therapy. J Sex Med (2012) 0.82
Anaplastic thyroid carcinoma. Front Endocrinol (Lausanne) (2012) 0.82
Specific induction of Akt3 in spinal cord motor neurons is neuroprotective in a mouse model of familial amyotrophic lateral sclerosis. Mol Neurobiol (2013) 0.82
Idiopathic infertility: effect of palmitoylethanolamide (a homologue of anandamide) on hyperactivated sperm cell motility and Ca2+ influx. J Androl (2005) 0.82
Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. Hypertension (2012) 0.82
Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease. J Clin Endocrinol Metab (2010) 0.82
Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase. Eur J Endocrinol (2003) 0.82
Progesterone increase counteracts aldosterone action in a pregnant woman with primary aldosteronism. Clin Endocrinol (Oxf) (2011) 0.82